Related Experiment Video
Updated: Jan 11, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
A Review of Multimodality Imaging in Hypertrophic Cardiomyopathy: Diagnosis, Risk Stratification, and Therapeutic
Rahul Gandhi1,2, Eng Lee Ooi3,4, Augustine Mugwagwa5,6
1Department of Cardiology, North Shore Hospital, Auckland, New Zealand.
Insights
Multimodality imaging, including echocardiography, MRI, nuclear imaging, and CT, is essential for diagnosing and managing hypertrophic cardiomyopathy (HCM). This integrated approach ensures precise diagnosis, risk stratification, and personalized treatment for better patient outcomes.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Hypertrophic cardiomyopathy (HCM) necessitates comprehensive imaging for diagnosis, risk assessment, and management.
- Echocardiography is the primary tool for assessing left ventricular wall thickness and outflow tract gradients.
Purpose of the Study:
- To highlight the importance of a multimodality imaging approach in evaluating hypertrophic cardiomyopathy.
- To detail the specific contributions of echocardiography, cardiovascular MRI, nuclear imaging, and cardiac CT.
Main Methods:
- Echocardiography for evaluating ventricular wall thickness, gradients, and mitral valve morphology.
- Cardiovascular MRI for myocardial mass, flow dynamics, and tissue characterization (late gadolinium enhancement, extracellular volume).
- Nuclear imaging for identifying HCM phenocopies (e.g., amyloidosis, sarcoidosis) and cardiac CT for coronary anatomy assessment.
Main Results:
- Multimodality imaging provides a comprehensive evaluation of HCM, distinguishing it from phenocopies.
- Each imaging modality offers unique strengths, contributing to precise diagnosis and risk stratification.
- Stress echocardiography aids in detecting dynamic gradients and planning interventions.
Conclusions:
- An integrated multimodal imaging approach is crucial for precise diagnosis, robust risk stratification, and individualized treatment planning in HCM.
- This comprehensive evaluation optimizes clinical decision-making and patient outcomes in hypertrophic cardiomyopathy.
- Combining echocardiography, MRI, nuclear imaging, and CT enhances the management of this complex myocardial disease.
Abstract:
Hypertrophic cardiomyopathy (HCM) requires multimodality imaging for accurate diagnosis, risk assessment, and management strategies. Echocardiography serves as the primary imaging tool, evaluating left ventricular wall thickness, outflow tract gradients, and mitral valve morphology. It provides essential diagnostic information and guides treatment decisions, with stress echocardiography particularly valuable for detecting dynamic gradients in obstructive HCM and supporting preoperative planning for interventions such as myectomy. Cardiovascular MRI complements echocardiography through superior resolution, enabling detailed assessment of myocardial mass, flow dynamics, and comprehensive tissue characterization. Late gadolinium enhancement and extracellular volume measurements enhance prognostic evaluation and risk stratification. Cardiac MRI excels at helping distinguish HCM from phenocopies like infiltrative or storage diseases and detecting myocardial disarray, microvascular dysfunction, and abnormalities in myocardial metabolism. Nuclear imaging proves crucial for identifying HCM phenocopies, including transthyretin amyloidosis and sarcoidosis, providing specific diagnostic capabilities. Cardiac CT, while having a secondary diagnostic role, becomes invaluable for evaluating coronary anatomy in patients considered for septal reduction therapies, ensuring comprehensive preoperative assessment. This integrated multimodal approach provides comprehensive HCM evaluation, enabling precise diagnosis, robust risk stratification, and individualized treatment planning. Each modality contributes unique strengths that collectively enhance clinical decision-making and optimize patient outcomes in this complex myocardial disease. Keywords: Cardiomyopathies, Applications-Multimodal, CT, Echocardiography, MR Imaging, SPECT, SPECT/CT, Cardiac Supplemental material is available for this article. © RSNA, 2025.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Imaging Studies for Cardiovascular System IV: CMRI

